DuPont Superconductivity Team Achieves, Thanks To 'Networking'

In early 1987, when research team around the world began reporting higher and higher superconductivity temperatures, several scientists at E. I. du Pont de Nemours & Co in Wilmington, Del., were touched by the fervor spreading throughout the scientific community. It was the spontaneous outpouring of enthusiasm by this group of bench scientists—rather than a sudden profit-motivated decision on the part of DuPont senior management—that resulted shortly thereafter in the company’

| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

And within a matter of months, the group had pulled off at least three major breakthroughs. These were made possible to a large extent by a refreshing show of corporate flexibility on the part of DuPont management—flexibility that permitted a kind of interdepartmental science networking not often seen in large-company environments.

Although DuPont has never been in the business of selling products that take advantage of superconductivity technology, the program that got underway last year was not its first foray into this field. In the mid-1960s, the company had launched an extensive effort pertaining to superconductors, a totally untargeted research project focusing on metal oxides and not aimed at any particular applications. By the mid- 1970s, however, progress had come to a standstill, the energy crisis had drawn many of DuPont’s scientists into what the company considered more important areas of research, and the project was nixed.

But the corporate ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Kenneth Friedman

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide